Am J Obstet Gynecol

1. CHMAIT RH, Korst LM, Llanes AS, Rallo KR, et al
   Randomized controlled trial of twin-twin transfusion syndrome laser surgery: the sequential trial.
   Am J Obstet Gynecol. 2024;231:365.
   

   >> Share

   
   

   
   Ann Hematol

2. EBEID FSE, Aly NH, Shaheen NM, Abdellatif SMA, et al
   Safety and efficacy of L-Glutamine in reducing the frequency of acute complications among patients with sickle cell disease: A randomized controlled study.
   Ann Hematol. 2024;103:3493-3506.
   

   >> Share

   
   
3. EZZAT EM, Bakr S, Golam RM, Abdelgyed BA, et al
   Adipocyte fatty acid-binding protein (FABP4) as a potential biomarker for predicting metabolically driven low-grade and organ damage in thalassemia syndromes.
   Ann Hematol. 2024;103:3473-3482.
   

   >> Share

   
   
4. JAJODIA E, Menghani H, Arora N, Jitani A, et al
   De-novo ATR-16 syndrome associated with inherited hemoglobin Evanston causing HbH phenotype: a rare occurrence.
   Ann Hematol. 2024;103:3805-3810.
   

   >> Share

   
   
5. PATSOURAKOS D, Aggeli C, Dimitroglou Y, Delicou S, et al
   Speckle tracking echocardiography and beta-thalassemia major. A systematic review.
   Ann Hematol. 2024;103:3335-3356.
   

   >> Share

   
   

   
   Int J Hematol

6. SAEIDNIA M, Shadfar F, Sharifi S, Babashahi M, et al
   Skin complications during iron chelation therapy for beta-thalassemia: overview and treatment approach.
   Int J Hematol. 2024;120:271-277.
   

   >> Share

   
   

   
   J Trop Pediatr

7. CORAIZIN C, Vreede H, Van Niekerk C, Joolay Y, et al
   Incidence, aetiology and short term outcomes of extreme hyperbilirubinaemia, in term infants born in the Western health subdistrict of Cape Town, South Africa between 2019 and 2020.
   J Trop Pediatr. 2024;70:fmae020.
   

   >> Share

   
   

   
   PLoS One

8. KAMVUMA K, Masenga S, Hamooya B, Chanda W, et al
   Prevalence and factors associated with moderate-to-severe anaemia among virally suppressed people with HIV at a tertiary hospital in Zambia.
   PLoS One. 2024;19:e0303734.
   

   >> Share

   
   

   
   Transplant Proc

9. ISHIYAMA Y, Yagisawa T, Ichioka M, Hagiwara A, et al
   Comparative Analysis of Real-World Efficacy and Safety of Hypoxia-Inducible Factor Prolyl-Hydroxylase Inhibitors in Kidney Transplant Recipients Versus Nontransplant Individuals: A Single-Center Study.
   Transplant Proc. 2024 Jul 5:S0041-1345(24)00349.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share